Search Results - "Björkholm, Magnus"
-
1
Expression and putative biological roles of lipoxygenases and leukotriene receptors in leukemia and lymphoma
Published in Prostaglandins & other lipid mediators (01-10-2024)“…This mini-review addresses lipoxygenases and receptors for leukotrienes in hematological malignancies. Potential novel biomarkers and drug targets in leukemia…”
Get full text
Journal Article -
2
Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and the United States
Published in Blood (25-07-2019)Get full text
Journal Article -
3
Leukemic transformation in myeloproliferative neoplasms: Therapy-related or unrelated?
Published in Best practice & research. Clinical haematology (01-06-2014)“…Polycythemia vera, essential thrombocythemia, and primary myleofibrosis are chronic myeloproliferative neoplasms (MPNs) associated with an increased morbidity…”
Get full text
Journal Article -
4
-
5
P076: Pneumococcal infection in splenectomised Hodgkin lymphoma patients: Do they pose a problem today and what is the best long‐term strategy?
Published in HemaSphere (03-10-2022)Get full text
Journal Article -
6
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Published in Blood (01-11-2008)“…Patients with multiple myeloma (MM) have an increased risk of deep venous thrombosis (DVT), particularly when treated with immunomodulatory drugs. Recently, 2…”
Get full text
Journal Article -
7
PB2001: PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES‐ A SWEDISH RETROSPECTIVE REAL‐WORLD STUDY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
8
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
Published in Blood (01-08-2002)“…This phase II study determined the efficacy and safety of alemtuzumab, a humanized anti-CD52 monoclonal antibody, delivered subcutaneously as first-line…”
Get full text
Journal Article -
9
How we treat elderly patients with Hodgkin lymphoma
Published in Current opinion in oncology (01-09-2011)“…PURPOSE OF REVIEWTo review Hodgkin lymphoma in older adults with regard to epidemiology, disease characteristics, prognosis, treatment, and future…”
Get full text
Journal Article -
10
No familial aggregation in chronic myeloid leukemia
Published in Blood (18-07-2013)Get full text
Journal Article -
11
Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
Published in European journal of haematology (01-05-2012)“…Background: Bacteremia is a major cause of morbidity and mortality in patients with hematological malignancies. Objectives: The aim of this study was to…”
Get full text
Journal Article -
12
Survival from Acute Lymphoblastic Leukemia (ALL) in Adult Patients in the United States and Sweden: Evidence of Recent Improvement
Published in BLOOD (06-12-2014)“…Introduction The improvement in pediatric ALL survival rates observed since the 1970xs has been achieved through a series of carefully conducted randomized…”
Get full text
Journal Article Conference Proceeding -
13
Activation of Telomerase by Human Cytomegalovirus
Published in JNCI : Journal of the National Cancer Institute (01-04-2009)“…Background The mechanism by which human cytomegalovirus (HCMV) stimulates oncogenesis is unclear. Because cellular immortalization and transformation require…”
Get full text
Journal Article -
14
Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden
Published in Journal of clinical oncology (20-04-2009)“…An association between socioeconomic status (SES) and survival in acute myeloid leukemia (AML) and multiple myeloma (MM) has not been established in developed…”
Get full text
Journal Article -
15
Patients’ perceptions of having a central venous catheter or a totally implantable subcutaneous port system–results from a randomised study in acute leukaemia
Published in Supportive care in cancer (01-02-2009)“…Goals of work The selection process of type of central venous access device (CVAD) in patients with acute leukaemia (AL) is generally based on appropriate…”
Get full text
Journal Article -
16
Mitogen-Activated Protein Kinase Cascade-Mediated Histone H3 Phosphorylation Is Critical for Telomerase Reverse Transcriptase Expression/Telomerase Activation Induced by Proliferation
Published in Molecular and Cellular Biology (01-01-2006)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
17
Switch from Myc/Max to Mad1/Max Binding and Decrease in Histone Acetylation at the telomerase reverse transcriptase Promoter during Differentiation of HL60 Cells
Published in Proceedings of the National Academy of Sciences - PNAS (27-03-2001)“…Recent evidence suggests that the Myc and Mad1 proteins are implicated in the regulation of the gene encoding the human telomerase reverse transcriptase…”
Get full text
Journal Article -
18
The absence of TERT promoter mutations in primary gastric cancer
Published in Gene (01-05-2014)“…•TERT promoter mutations activating telomerase occur in certain types of cancer.•The mutations were not detected in cancer tissue from 200 gastric cancer…”
Get full text
Journal Article -
19
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
Published in Seminars in oncology (01-04-2003)“…This presentation represents consensus recommendations on prognostic markers and criteria to initiate therapy in patients with Waldenstrom's macroglobulinemia…”
Get full text
Journal Article -
20
Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles
Published in Blood (19-11-2010)“…Abstract 4868 Bacteremia is a major cause of morbidity and mortality in patients with hematological disorders during chemotherapy-induced neutropenia. Initial…”
Get full text
Journal Article